title: Treatment of preexisting diabetes with olanzapine.
authors.forename: K H
authors.initials: KH
authors.lastname: Littrell
authors.forename: R G
authors.initials: RG
authors.lastname: Petty
authors.forename: C D
authors.initials: CD
authors.lastname: Peabody
authors.forename: N M
authors.initials: NM
authors.lastname: Hilligoss
authors.forename: C G
authors.initials: CG
authors.lastname: Johnson
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010349:Patient Compliance; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011788:Quality of Life; D012563:Schizophrenia, Paranoid / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D003024:Clozapine; D000077152:Olanzapine